Shionogi Presents Real-World Evidence Showing Strong Efficacy with Fetroja® (cefiderocol) Against Treatment Resistant Bacterial Infections at IDWeek 2022
Real-world evidence demonstrated that Fetroja achieved clinical cure in 63% of patients with Acinetobacter baumannii…